422 related articles for article (PubMed ID: 29398127)
1. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
[TBL] [Abstract][Full Text] [Related]
2. Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
Grimm J; Vargo JA; Mavroidis P; Moiseenko V; Emami B; Jain S; Caudell JJ; Clump DA; Ling DC; Das S; Moros EG; Vinogradskiy Y; Xue J; Heron DE
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):147-159. PubMed ID: 33583641
[TBL] [Abstract][Full Text] [Related]
3. Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: A multi-institutional matched-cohort analysis.
Yamazaki H; Ogita M; Himei K; Nakamura S; Kotsuma T; Yoshida K; Yoshioka Y
Radiother Oncol; 2015 Apr; 115(1):67-71. PubMed ID: 25827266
[TBL] [Abstract][Full Text] [Related]
4. Fitting NTCP models to SBRT dose and carotid blowout syndrome data.
Mavroidis P; Grimm J; Cengiz M; Das S; Tan X; Yazici G; Ozyigit G
Med Phys; 2018 Oct; 45(10):4754-4762. PubMed ID: 30102783
[TBL] [Abstract][Full Text] [Related]
5. Risk of carotid blowout after reirradiation of the head and neck: a systematic review.
McDonald MW; Moore MG; Johnstone PA
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1083-9. PubMed ID: 21549520
[TBL] [Abstract][Full Text] [Related]
6. Dose-response modeling the risk of carotid bleeding events after stereotactic body radiation therapy for previously irradiated head and neck cancer.
Ling DC; Vargo JA; Gebhardt BJ; Grimm RJ; Clump DA; Ferris RL; Ohr JP; Heron DE
J Radiosurg SBRT; 2019; 6(2):83-89. PubMed ID: 31641545
[TBL] [Abstract][Full Text] [Related]
7. A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiaton for recurrent head and neck cancers.
Yazici G; Sanlı TY; Cengiz M; Yuce D; Gultekin M; Hurmuz P; Yıldız F; Zorlu F; Akyol F; Gurkaynak M; Ozyigit G
Radiat Oncol; 2013 Oct; 8():242. PubMed ID: 24139288
[TBL] [Abstract][Full Text] [Related]
8. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
[TBL] [Abstract][Full Text] [Related]
9. Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck.
Echevarria MI; Yang GQ; Chen DT; Kirtane K; Russell J; Kish J; Muzaffar J; Otto K; Padhya T; McMullen C; Patel K; Chung CH; Caudell JJ
Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):341-347. PubMed ID: 37105404
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
[TBL] [Abstract][Full Text] [Related]
11. Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis.
Caudell JJ; Ward MC; Riaz N; Zakem SJ; Awan MJ; Dunlap NE; Isrow D; Hassanzadeh C; Vargo JA; Heron DE; Marcrom S; Boggs DH; Reddy CA; Dault J; Bonner JA; Higgins KA; Beitler JJ; Koyfman SA; Machtay M; Yao M; Trotti AM; Siddiqui F; Lee NY;
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):606-617. PubMed ID: 29413274
[TBL] [Abstract][Full Text] [Related]
12. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
13. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
[TBL] [Abstract][Full Text] [Related]
14. Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience.
Held T; Windisch P; Akbaba S; Lang K; El Shafie R; Bernhardt D; Plinkert P; Kargus S; Rieken S; Herfarth K; Debus J; Adeberg S
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):803-811. PubMed ID: 31349059
[TBL] [Abstract][Full Text] [Related]
15. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
16. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
Vargo JA; Ward MC; Caudell JJ; Riaz N; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Higgins KA; Hassanadeh C; Beitler JJ; Reddy CA; Marcrom S; Boggs DH; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA; Ferris RL; Heron DE
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):595-605. PubMed ID: 28899556
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
18. Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer.
Bergamin S; Eade T; Kneebone A; Booth J; Hsiao E; Schembri GP; Szymura K; Le A; Kwong C; Brown C; Hunter J; Hruby G
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1172-1178. PubMed ID: 32659332
[TBL] [Abstract][Full Text] [Related]
19. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
[TBL] [Abstract][Full Text] [Related]
20. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
